L. Barbieri

发表

Takotsubo syndrome in COVID-19 era: Is psychological distress the key?

G. Pravettoni, L. Barbieri, F. Galli, 2020, Journal of Psychosomatic Research.

Impact of diabetes on uric acid and its relationship with the extent of coronary artery disease and platelet aggregation: a single-centre cohort study.

G. De Luca, P. Marino, G. Bellomo, 2014, Metabolism: clinical and experimental.

Benefits From New ADP Antagonists as Compared With Clopidogrel in Patients With Stable Angina or Acute Coronary Syndrome Undergoing Invasive Management: A Meta-analysis of Randomized Trials

G. De Luca, P. Marino, G. Galasso, 2014, Journal of cardiovascular pharmacology.

Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve

H. Suryapranata, G. De Luca, P. Marino, 2017, Coronary artery disease.

Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.

H. Suryapranata, D. Dudek, G. De Luca, 2021, Atherosclerosis.

GENDER DIFFERENCES IN PLATELET REACTIVITY IN PATIENTS RECEIVING DUAL ANTIPLATELET THERAPY

H. Suryapranata, P. Marino, L. Barbieri, 2016 .

Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview

H. Suryapranata, G. De Luca, L. Barbieri, 2015, Platelets.

Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy

H. Suryapranata, P. Marino, G. Bellomo, 2016, Cardiovascular Drugs and Therapy.

Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients.

H. Suryapranata, G. De Luca, G. Bellomo, 2016, Thrombosis research.

Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Vascular pharmacology.

Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Expert opinion on pharmacotherapy.

Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.

Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients

H. Suryapranata, G. De Luca, P. Marino, 2018, Pharmacological research.

Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Optimal Duration of Dual Antiplatelet Therapy After DES Implantation

H. Suryapranata, G. De Luca, A. Colombo, 2016, Angiology.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2017, Thrombosis research.

Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease

P. Marino, L. Barbieri, M. Verdoia, 2015, Journal of Thrombosis and Thrombolysis.

Meta-Analysis of Placebo-Controlled Trials of Levosimendan in Acute Myocardial Infarction

L. Barbieri, S. Lucreziotti, A. Mafrici, 2021, Journal of cardiovascular development and disease.

Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2019, Journal of cardiology.

Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2015, Diabetes research and clinical practice.

Effect of diabetes mellitus on periprocedural myocardial infarction in patients undergoing coronary stent implantation

G. De Luca, P. Marino, G. Bellomo, 2015, Diabetes/metabolism research and reviews.

Systematic review and meta-analysis on coronary calcifications in COVID-19

L. Barbieri, S. Lucreziotti, A. Mafrici, 2022, Emergency Radiology.

Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease

P. Marino, L. Barbieri, M. Verdoia, 2015, Angiology.

Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

Predictors of Mortality and Long-Term Outcome in Patients with Anterior STEMI: Results from a Single Center Study

L. Barbieri, S. Lucreziotti, S. Carugo, 2021, Journal of clinical medicine.

Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.

H. Suryapranata, G. De Luca, P. Marino, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2015, Thrombosis research.

The role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trials

P. Marino, L. Barbieri, M. Verdoia, 2014, Journal of Thrombosis and Thrombolysis.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2016, Thrombosis research.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty

H. Suryapranata, G. De Luca, P. Marino, 2014, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.

G. De Luca, P. Marino, L. Barbieri, 2016, Atherosclerosis.

Impact of red blood cells count on the relationship between high density lipoproteins and the prevalence and extent of coronary artery disease: a single centre study [corrected].

G. De Luca, P. Marino, L. Barbieri, 2015 .

Vitamin D deficiency is independently associated with the extent of coronary artery disease

G. De Luca, P. Marino, G. Galasso, 2014, European journal of clinical investigation.

Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis.

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Revista espanola de cardiologia.

Influence of Different COVID-19 Pandemic Phases on STEMI: Experience From an Italian Hub Centre

L. Barbieri, B. Conconi, S. Lucreziotti, 2021, Cardiovascular Revascularization Medicine.

Impact of neutrophil-to-lymphocyte ratio on periprocedural myocardial infarction in patients undergoing non-urgent percutaneous coronary revascularisation

H. Suryapranata, G. De Luca, P. Marino, 2016, Netherlands Heart Journal.

Impact of 719Trp>Arg Polymorphism of KIF 6 Gene on Contrast Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention

H. Suryapranata, G. De Luca, L. Barbieri, 2022, Global heart.

Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Platelet distribution width and the risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention

G. De Luca, P. Marino, G. Bellomo, 2014, Journal of Thrombosis and Thrombolysis.

Gender differences with short-term vs 12 months dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-years follow-up results of the REDUCE trial

H. Suryapranata, G. De Luca, A. V. Van't Hof, 2021, Journal of Thrombosis and Thrombolysis.

Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta‐analysis of randomized trials

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Advanced age and high‐residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of thrombosis and haemostasis : JTH.

Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity

H. Suryapranata, G. De Luca, P. Marino, 2018, Angiology.

Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Cardiovascular therapeutics.

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.

H. Suryapranata, G. De Luca, L. Barbieri, 2018, Thrombosis research.

Impact of Female Gender on Acute and Mid-Term Mortality in Patients with ST-Segment Elevation Myocardial Infarction during the Pandemic Era

L. Barbieri, S. Carugo, G. Tumminello, 2022, Women.

Out-of-hospital cardiac arrest: always coronary angiography?

L. Barbieri, A. Rognoni, M. Mennuni, 2017, Expert review of cardiovascular therapy.

Bivalirudin Versus Unfractionated Heparin in Acute Coronary Syndromes: An Updated Meta-analysis of Randomized Trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Revista espanola de cardiologia.

Determinants of the protective effect of glucocorticoids on mortality in hospitalized patients with COVID-19

M. Metra, M. Senni, I. Porto, 2021, International Journal of Infectious Diseases.

Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment.

H. Suryapranata, G. De Luca, L. Barbieri, 2019, International journal of cardiology.

Radial vs Femoral Approach in Acute Coronary Syndromes: A Meta- Analysis of Randomized Trials.

H. Suryapranata, G. De Luca, L. Barbieri, 2017, Current vascular pharmacology.

Outcomes of acute coronary syndromes in coronavirus disease 2019

F. Fedele, R. Manka, M. Mancone, 2020, Clinical Research in Cardiology.

Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy

H. Suryapranata, G. De Luca, P. Marino, 2015, Cardiovascular Drugs and Therapy.

ST-segment elevation myocardial infarction care during the COVID-19 health emergency: the organization of one Hub center in Milan, Italy

L. Barbieri, B. Conconi, S. Lucreziotti, 2021 .

Impact of COVID-19 on STEMI: Second youth for fibrinolysis or time to centralized approach?

L. Barbieri, B. Conconi, S. Lucreziotti, 2020, IJC Heart & Vasculature.

ST-Elevation Myocardial Infarction in Patients With COVID-19

D. Andreini, G. Condorelli, M. Metra, 2020, Circulation.

Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI

H. Suryapranata, G. De Luca, P. Marino, 2014, Platelets.

Uric acid and risk of periprocedural myocardial infarction in patients undergoing percutaneous coronary intervention

G. De Luca, P. Marino, L. Barbieri, 2014, Diabetes/metabolism research and reviews.

Mean platelet volume and the risk of periprocedural myocardial infarction in patients undergoing coronary angioplasty.

H. Suryapranata, G. De Luca, P. Marino, 2013, Atherosclerosis.

Mortality in STEMI Patients During the COVID Era: Has the Pandemic Changed Our Clinical Practice?

L. Barbieri, B. Conconi, S. Lucreziotti, 2020, Cardiovascular Revascularization Medicine.

Contrast volume to creatinine clearance ratio for the prediction of contrast-induced nephropathy in patients undergoing coronary angiography or percutaneous intervention

H. Suryapranata, G. De Luca, P. Marino, 2016, European journal of preventive cardiology.

Pre-diabetes and the risk of contrast induced nephropathy in patients undergoing coronary angiography or percutaneous intervention.

H. Suryapranata, G. De Luca, P. Marino, 2014, Diabetes research and clinical practice.

Platelet–larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization

P. Marino, G. Bellomo, L. Barbieri, 2013, Heart and Vessels.

Clinical Management of New-Onset Atrial Fibrillation in COVID-19 Patients Referred to a Tertiary Cardiac Arrhythmia Center after Hospital Discharge

L. Barbieri, S. Carugo, F. Sozzi, 2022, Journal of clinical medicine.

Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention.

H. Suryapranata, G. De Luca, L. Barbieri, 2019, International journal of cardiology.

Systematic review and meta-analysis on coronary calcifications in COVID-19

L. Barbieri, S. Lucreziotti, A. Mafrici, 2022, Emergency Radiology.

Antiplatelet therapy in ACS elderly patients: Another piece of this intriguing puzzle.

G. De Luca, L. Barbieri, M. Verdoia, 2021, International journal of cardiology.

[Effectiveness of the Palmaz Schatz stent in elderly patients with unstable angina: factors predictive of short-term and long-term events].

A. di Lenarda, L. Barbieri, G. Sinagra, 1997, Giornale italiano di cardiologia.

Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature

L. Barbieri, S. Carugo, Andrea Faggiano, 2022, Journal of clinical medicine.

Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study

H. Suryapranata, P. Marino, G. Bellomo, 2015, Experimental Gerontology.

IncidenCe and predictOrs of heaRt fAiLure after acute coronarY Syndrome: The CORALYS registry.

M. Scaglione, L. Barbieri, G. Campo, 2022, International journal of cardiology.

Diabetes, glucose control and mean platelet volume: a single-centre cohort study.

G. De Luca, P. Marino, G. Bellomo, 2014, Diabetes research and clinical practice.

Are There Differences in the Demographics and Clinical Outcomes Between Asian and European Patients Treated With the COMBO Dual Therapy Stent in the REDUCE Trial Populations?

H. Suryapranata, G. De Luca, L. Barbieri, 2022, Journal of Asian Pacific Society of Cardiology.

Acute myocarditis after the second dose of SARS-CoV-2 vaccine: Serendipity or atypical causal relationship?

L. Barbieri, S. Lucreziotti, A. Mafrici, 2021, Anatolian journal of cardiology.

L. Barbieri, S. Carugo, G. Tumminello, 2022, Journal of cardiovascular development and disease.

Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry

G. Musumeci, L. Barbieri, G. Campo, 2021, International Journal of Cardiology.

COVID-19 in Chronic Kidney Disease: The Impact of Old and Novel Cardiovascular Risk Factors

L. Barbieri, S. Carugo, M. A. Podestà, 2021, Blood Purification.

The Impact of Old and Novel Cardiovascular Risk Factors

L. Barbieri, S. Carugo, M. A. Podestà, 2021 .

Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2015, Diabetes & metabolism.

New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome

L. Barbieri, S. Lucreziotti, S. Carugo, 2021, Diagnostics.

Impact of heart failure on the clinical course and outcomes of patients hospitalized for COVID‐19. Results of the Cardio‐COVID‐Italy multicentre study

M. Metra, M. Senni, I. Porto, 2020, European journal of heart failure.

Impact of renal function on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study.

G. De Luca, P. Marino, G. Bellomo, 2016, Thrombosis research.

Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients.

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of diabetes and its complications.

Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease

H. Suryapranata, G. De Luca, P. Marino, 2016, Angiology.

Homocysteine and risk of periprocedural myocardial infarction in patients undergoing coronary stenting

G. De Luca, P. Marino, L. Barbieri, 2015, Journal of cardiovascular medicine.

Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.

Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents

H. Suryapranata, G. De Luca, L. Barbieri, 2018, Angiology.

MTHFR polymorphism and risk of periprocedural myocardial infarction after coronary stenting.

G. De Luca, P. Marino, L. Barbieri, 2014, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Glycosylated hemoglobin and coronary artery disease in patients without diabetes mellitus.

G. De Luca, P. Marino, L. Barbieri, 2014, American journal of preventive medicine.

Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Optical Coherence Tomography and Coronary Dissection: Precious Tool or Useless Surplus?

G. Guagliumi, L. Barbieri, S. Carugo, 2022, Frontiers in Cardiovascular Medicine.

High-Density Lipoproteins and Coronary Artery Disease

H. Suryapranata, P. Marino, L. Barbieri, 2014, Angiology.

Impact of RAAS Inhibitors on Clinical Outcome and Mortality in Patients With STEMI During the COVID-19 Era: A Multicenter Observational Study

M. Metra, L. Barbieri, S. Carugo, 2021, Frontiers in Cardiovascular Medicine.

Systematic Review and Meta-Analysis of Oral Anticoagulant Therapy in Atrial Fibrillation Cancer Patients

G. Sangiorgi, L. Barbieri, B. Conconi, 2023, Cancers.

Gender Difference in the Risk of Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography or Percutaneous Coronary Intervention

H. Suryapranata, G. De Luca, P. Marino, 2017, Angiology.

Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies

H. Suryapranata, L. Barbieri, M. Verdoia, 2016, Cardiovascular Drugs and Therapy.

Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: rationale and design of the REDUCE trial.

H. Suryapranata, G. De Luca, M. de Boer, 2016, American heart journal.

Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Annals of Nutrition and Metabolism.

Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy

H. Suryapranata, G. Niccoli, P. Marino, 2015, Angiology.

Eosinophils count and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions.

H. Suryapranata, G. De Luca, P. Marino, 2014, Atherosclerosis.

Secondary prevention and follow-up of patients with ACS and not-at-target LDL: An Italian real-world retro-prospective analysis by the inertia group

N. Brunetti, F. Fedele, F. Prati, 2023, International journal of cardiology. Cardiovascular risk and prevention.

Predictors of procedural and clinical outcome in rotational atherectomy: analysis of a single centre registry.

L. Barbieri, S. Lucreziotti, S. Carugo, 2020, Minerva cardioangiologica.

DUAL ANTIPLATELET THERAPY VERSUS SINGLE ANTIPLATELET REGIMEN WITH OR WITHOUT ANTICOAGULATION IN TRANSCATHETER AORTIC VALVE REPLACEMENT: INDIRECT COMPARISON AND META-ANALYSIS

H. Suryapranata, P. Marino, L. Barbieri, 2017 .

Impact of Complete Revascularization on Development of Heart Failure in Patients With Acute Coronary Syndrome and Multivessel Disease: A Subanalysis of the CORALYS Registry.

M. Scaglione, L. Barbieri, E. Abu-Assi, 2023, Journal of the American Heart Association.

In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention.

L. Barbieri, S. Carugo, E. Cerrato, 2021, Minerva cardiology and angiology.

Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease.

G. De Luca, L. Barbieri, M. Verdoia, 2018, Platelets.

Versus Unfractionated Heparin in Acute Coronary Syndromes : An Updated Meta-analysis of Randomized Trials

H. Suryapranata, L. Barbieri, M. Verdoia, 2019 .

Right Heart Catheterization: An Antecubital Vein Approach to Reduce Fluoroscopy Time, Radiation Dose, and Guidewires Need

L. Barbieri, S. Carugo, F. Colombo, 2023, Journal of clinical medicine.

Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions

F. Burzotta, C. Trani, G. Niccoli, 2021, Journal of cardiovascular medicine.

Versus Unfractionated Heparin in Acute Coronary Syndromes : An Updated Meta-analysis of Randomized Trials

H. Suryapranata, L. Barbieri, M. Verdoia, 2019 .

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Benefits From New ADP Antagonists as Compared With Clopidogrel in Patients With Stable Angina or Acute Coronary Syndrome Undergoing Invasive Management: A Meta-analysis of Randomized Trials

G. De Luca, P. Marino, G. Galasso, 2014, Journal of cardiovascular pharmacology.

Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.

H. Suryapranata, G. De Luca, L. Barbieri, 2016, Vascular pharmacology.

Vitamin D status, diabetes mellitus and coronary artery disease in patients undergoing coronary angiography.

G. De Luca, P. Marino, L. Barbieri, 2016, Atherosclerosis.

Ventricular ectopy following accessory pathway ablation in WPW syndrome.

L. Barbieri, S. Carugo, M. Saviano, 2021, Journal of electrocardiology.

Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy

H. Suryapranata, G. Niccoli, P. Marino, 2015, Angiology.